The National Agency for Food and Drugs Administration and Control, NAFDAC, has raised the alarm over the circulation of suspected counterfeit Augmentin 625mg Tablets in the country.

In a statement titled ‘NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg’, the regulatory agency said the product fell short of the labelling requirements.

According to the statement, the suspected falsified Augmentin which was manufactured in April 2021 would expire on April 2024.

It also stated that the batch number of the falsified drug is 562626 with a NAFDAC registration number- 04-1928.

NAFDAC said it has notified all its formations in the zones and 36 states of the federation including the FCT to carry out surveillance and mop up the falsified Augmentin tablets.